SAMiRNA-Magnetic Nanoparticle Complex for Targeted Cancer Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering therapeutic agents, such as siRNA, face challenges in achieving precise and selective targeting of cancer cells due to instability and non-specific delivery, leading to inefficient therapy and potential side effects, while magnetic nanoparticles require improved biocompatibility and stability for effective in vivo use.
Innovation Solution
A SAMiRNA-magnetic nanoparticle complex is developed, comprising magnetic nanoparticles coated with a first hydrophobic material and a double-stranded oligo RNA structure bound with hydrophilic and hydrophobic materials via covalent bonds, enhanced by a target-specific ligand for improved delivery and stability, allowing for simultaneous therapy and diagnosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If magnetic nanoparticles are used for drug delivery, then delivery to target area is improved, but biocompatibility and stability are insufficient
Solution Approach 1:
The patent creates a composite nanoparticle system combining magnetic nanoparticles (Fe3O4) with cationic lipids and siRNA. The magnetic nanoparticle core provides targeting capability, while the cationic lipid shell enhances biocompatibility and stability. This composite structure resolves the contradiction by integrating materials with complementary properties - the magnetic component enables reliable delivery while the lipid coating provides biocompatibility and structural stability.
2Reliability
If siRNA is delivered using conventional methods, then therapy is provided, but delivery precision and selectivity are poor leading to side effects
Solution Approach 1:
The patent employs a nested structure where siRNA is encapsulated within the cationic lipid shell, which in turn surrounds the magnetic nanoparticle core. This nested arrangement protects the siRNA during circulation, enables magnetic targeting for precise delivery to tumor cells, and reduces off-target effects. The selective delivery to cancer cells through magnetic guidance and cellular uptake mechanisms resolves the contradiction between therapy effectiveness and delivery precision.
3Adaptability or versatility
If imaging agents and drugs are delivered separately, then diagnosis and therapy are performed, but simultaneous theragnosis is not achieved
Solution Approach 1:
The patent creates a multifunctional nanoparticle platform that simultaneously performs imaging and therapy functions. The magnetic nanoparticle core serves dual purposes: as a contrast agent for MRI imaging and as a targeting vehicle for siRNA delivery. The cationic lipid shell enables both protection of the therapeutic agent and facilitation of cellular uptake. This single nanoparticle system integrates diagnosis (imaging) and therapy (siRNA delivery) capabilities, achieving theragnosis without requiring separate delivery systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The SAMiRNA-magnetic nanoparticle complex enhances cell delivery efficiency, improves in vivo stability, and enables precise targeting of cancer cells, allowing for effective therapy and diagnosis, thereby overcoming issues of non-specific delivery and instability in existing technologies.
Implementation Method 1
The SAMiRNA-magnetic nanoparticle complex may be formed by an interaction between the hydrophobic material in the SAMiRNA and the hydrophobic material coated onto a surface of the magnetic materials of the magnetic nanoparticles
Implementation Method 2
The magnetic nanoparticles shorten a spin-spin relaxation time of the hydrogen atoms of water molecules around the nanoparticles to amplify MRI signal
Implementation Method 3
The drug or the gene is loaded on the magnetic nanoparticle by chemical bond or absorption and moved to a desired position by an external magnetic field
Data Source
Figure 1
Figure 2
Figure 3A~3B
AI summary
Provided are a SAMiRNA-magnetic nanoparticle complex capable of effectively delivering a double-stranded oligo RNA and magnetic nanoparticles into a cell and a composition capable of simultaneously performing diagnosis and therapy of diseases such as cancer, and the like, containing the same. More specifically, provided is the SAMiRNA-magnetic nanoparticle complex consisting of double-stranded oligo RNA-polymer structures in which a hydrophilic material and a second hydrophobic material are bound to the double-stranded oligo RNA by a simple covalent bond or a linker-mediated covalent bond, and the magnetic nanoparticles in which a first hydrophobic material is bound onto a surface of the magnetic material, as a core. The SAMiRNA-magnetic nanoparticle complex may have a homogeneous size by a hydrophobic interaction between the first hydrophobic material of the present invention and the second hydrophobic material of the double-stranded oligo RNA structure. In addition, the hydrophilic material and the second hydrophobic material bound to the double-stranded oligo RNA structure may improve in vivo stability of the double-stranded oligo RNA, an additionally bound ligand may deliver the SAMiRNA-magnetic nanoparticle complex into a target cell even at a relative low concentration of dosage, and the magnetic materials of the magnetic nanoparticles may be used as an imaging agent for diagnosis.